| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AERIE PHARMACEUTICALS INC COM | 1,598,452 | 60,501,000 | 26.29% | ||
| 2 | ACHAOGEN INC COM | 2,607,984 | 33,956,000 | 14.76% | ||
| 3 | ALDER BIOPHARMACEUTICALS INC | 1,628,328 | 33,869,000 | 14.72% | ||
| 4 | AIMMUNE THERAPEUTICS INC COM | 903,890 | 18,485,000 | 8.03% | ||
| 5 | WAVE LIFE SCIENCES LTD | 676,128 | 17,681,000 | 7.68% | ||
| 6 | NANOSTRING TECHNOLOGIES INC | 438,133 | 9,770,000 | 4.25% | ||
| 7 | INTELLIA THERAPEUTICS INC | 703,563 | 9,224,000 | 4.01% | ||
| 8 | BLUEPRINT MEDICINES CORP COM | 300,000 | 8,415,000 | 3.66% | ||
| 9 | Protagonist Therapeutics, Inc. | 346,281 | 7,615,000 | 3.31% | ||
| 10 | EPIZYME INC COM | 605,239 | 7,323,000 | 3.18% | ||
| 11 | iRhythm Technologies, Inc. | 166,210 | 4,986,000 | 2.17% | ||
| 12 | EDITAS MEDICINE INCORPORATED | 274,910 | 4,462,000 | 1.94% | ||
| 13 | ACLARIS THERAPEUTICS INC COM | 155,767 | 4,228,000 | 1.84% | ||
| 14 | Ascendis Pharma | 180,000 | 3,643,000 | 1.58% | ||
| 15 | ZAFGEN INC COM | 469,404 | 1,493,000 | 0.65% | ||
| 16 | AKARI THERAPEUTICS PLC | 197,072 | 1,387,000 | 0.60% | ||
| 17 | Audentes Therapeutics, Inc. | 66,553 | 1,216,000 | 0.53% | ||
| 18 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 63,627 | 919,000 | 0.40% | ||
| 19 | ACCELERON PHARMA INC | 19,886 | 507,000 | 0.22% | ||
| 20 | OREXIGEN THERAPEUTICS INC | 254,257 | 442,000 | 0.19% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-007452, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
